Oxford University suspends AstraZeneca vaccine trial on children
Oxford University announced on Tuesday that it was suspending a trial of the Covid-19 vaccine that it developed with AstraZeneca on children and teenagers while British regulators investigate a potential blood clot link in adults, Euronews reported.
“Whilst there are no safety concerns in the paediatric clinical trial, we await additional information from the MHRA on its review of rare cases of thrombosis/thrombocytopaenia that have been reported in adults, before giving any further vaccinations in the trial," the university said in a statement.
"Parents and children should continue to attend all scheduled visits and can contact the trial sites if they have any questions.”
The Medicines and Healthcare Regulatory Agency (MHRA) revealed on Saturday that seven people in the country had died from rare blood clots after getting the shot out of a total of 30 identified cases, while more than 18 million doses were administered in the country.
The British regulator said it wasn't clear if the shots are causing the clots.
Related news
- UK finds 30 blood clot cases after AstraZeneca vaccine use
- Man hospitalized with blood clots after receiving AstraZeneca vaccine in Australia
- Germany's vaccine regulator reports 31 cases of blood disorder after AstraZeneca shot
- Canada stops using AstraZeneca’s Covid-19 vaccine for people under 55
- European trust in AstraZeneca coronavirus vaccine plunges, survey shows